Friday, April 19, 2019
    Latest

    Psoriasis

    Home Psoriasis
    Psoriasis

    Otezla; An Introduction

    0
    China Pharma
    Psoriasis

    PharmaWatch: Novartis Receives Approval for Psoriasis Drug Cosentyx in China

    0
    Psoriasis

    Sourasky Medical Centre to Execute Study for OWC Pharma

    0
    Psoriasis

    Psoriasis Patient Takes Autoimmune Disorder to Facebook Live and Shares Struggles

    0
    Skin condition
    Psoriasis

    Novartis Joins TARGET PharmaSolutions for Longitudinal Dermatology Study with DNA BioBank

    0
    Psoriasis

    UCB’s Bimekizumab Demonstrates Positive Results from BE ABLE Study

    0
    Psoriasis
    Psoriasis

    NHLBI Study Finds Biologic Drugs May Prevent Heart Disease in Patients...

    0
    Psoriasis

    Study Links Psoriasis Treatment With Improvement in Heart Artery Disease

    0
    Psoriasis

    USC Research Finds Psoriasis Online Care Delivery Model Equivalent to In-Person

    0
    Psoriasis

    Abbvie Reporting Risankizumab Effective for Moderate to Severe Psoriasis

    0
    12Page 1 of 2
    - Advertisement -

    EDITOR PICKS

    TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

    307 West 200 South #5002
    Salt Lake City, UT 84101

    Contact us: admin@trialsitenews.com
    © TrialSite News, Inc. All Rights Reserved